Anavex Life Sciences Corp (AVXL)

[stealthways]

AVXL should benefit from the governments drive to lower costs in healthcare.... The market has not figured this (innovative drugs lowering disease management costs) out yet but the goal of the government is to lower overall costs (and there is a huge difference here between existing drugs and effective drugs in development) .... Bringing in new drugs that lower disease management costs will be factored into the evaluation of how new policies are developed .... there will be pressure to lower generic drug prices especially and even (but to a lessor extent) RX drugs already approved.... but new drugs under development like 273, will benefit since if they show effectiveness and lower maintenance costs of large disease this is exactly what the big picture fiscal plans are being designed for ....perfect alignment....